CIHR Team Grant & OICR Smarter Imaging Program (SIP)
in Prostate Cancer
November 16, 2012 London Ontario
- Educate the audience regarding the CIHR Team Grant and OICR Smarter Imaging Program initiatives.
- Familiarize the audience with new imaging techniques being developed and validated for the diagnosis and management of prostate cancer.
- Participate in the identification of issues regarding the implementation of new imaging techniques in prostate cancer.
Accuracy of 18F-FDG-PET/CT in Primary Staging of Biological High Risk Prostate Cancers (Gleason >7) Before Local Therapies
Frederic Pouliot, MD, PhD, FRCSC, Urologist-Oncologist and Assistant Professor, Department of Surgery, Urology Division, Université Laval, Québec
PET Imaging of Prostate Cancer Using Ghrelin
Leonard Luyt, PhD, Assistant Professor, Department of Chemistry, UWO; Scientist, London Regional Cancer Program, LHSC
MRI in Active Surveillance
Masoom Haider, MD, FRCPC, Professor, Departments of Radiation Oncology and Medical Imaging, University of Toronto; Associate Scientist, Sunnybrook Research Institute, Toronto
Prostate MRI: From Diagnosis to Therapy
Baris Turkbey, MD, Molecular Imaging Program, NCI, NIH, Bethesda, Maryland, USA
PET/MR: Update and Future Directions
Jonathan Mandel, MD, FRCPC, Radiology and Nuclear Medicine, Assistant Professor, Department of Medical Imaging, Western University
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada and approved by Continuing Professional Development, Schulich School of Medicine & Dentistry, The University of Western Ontario. (3.0 hours)
This program has no commercial support.